Design, synthesis and evaluation of furanocoumarin monomers as inhibitors of CYP3A4
about
Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene.Novel coumarin glycoside and phenethyl vanillate from Notopterygium forbesii and their binding affinities for opioid and dopamine receptors.Inositol Derivatives and Phenolic Compounds from the Roots of Taraxacum coreanum.Selective oxidation reactions of natural compounds with hydrogen peroxide mediated by methyltrioxorhenium.A new HPLC method developed for the analysis of oxygen heterocyclic compounds inCitrusessential oils
P2860
Design, synthesis and evaluation of furanocoumarin monomers as inhibitors of CYP3A4
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Design, synthesis and evaluation of furanocoumarin monomers as inhibitors of CYP3A4
@ast
Design, synthesis and evaluation of furanocoumarin monomers as inhibitors of CYP3A4
@en
Design, synthesis and evaluation of furanocoumarin monomers as inhibitors of CYP3A4
@nl
type
label
Design, synthesis and evaluation of furanocoumarin monomers as inhibitors of CYP3A4
@ast
Design, synthesis and evaluation of furanocoumarin monomers as inhibitors of CYP3A4
@en
Design, synthesis and evaluation of furanocoumarin monomers as inhibitors of CYP3A4
@nl
prefLabel
Design, synthesis and evaluation of furanocoumarin monomers as inhibitors of CYP3A4
@ast
Design, synthesis and evaluation of furanocoumarin monomers as inhibitors of CYP3A4
@en
Design, synthesis and evaluation of furanocoumarin monomers as inhibitors of CYP3A4
@nl
P2093
P356
P1476
Design, synthesis and evaluation of furanocoumarin monomers as inhibitors of CYP3A4
@en
P2093
A V Stachulski
M S Lennard
P304
P356
10.1039/B601096B
P407
P577
2006-04-21T00:00:00Z